GX1 fundamentals
Key facts
Market capitalization20.16 MPLN
Basic EPS (TTM)−1.15PLN
Founded2016
Employees (FY)16.25
CEOMichal Kaszuba
Websitegenxone.eu
About
GenXone SA is a biotechnology company, which engages in the development of products and solutions based on the latest technologies of nucleic acid sequencing. It also offers diagnostic tests. The company was founded by Michal Kaszuba in 2016 and is headquartered in Suchy Las, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−270%
−240%
−210%
−180%
−150%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−2.10 M
−1.40 M
−700.00 K
0.00
700.00 K
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company